• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FeO 涂层 CNTs-阿拉伯胶纳米杂化复合材料通过 ROS 介导的信号转导增强抗白血病活性,针对 AML 细胞。

FeO-Coated CNTs-Gum Arabic Nano-Hybrid Composites Exhibit Enhanced Anti-Leukemia Potency Against AML Cells via ROS-Mediated Signaling.

机构信息

Department of Biochemistry, Faculty of Science, Ain Shams University, Cairo, 11566, Egypt.

Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Kingdom of Saudi Arabia.

出版信息

Int J Nanomedicine. 2024 Jul 19;19:7323-7352. doi: 10.2147/IJN.S467733. eCollection 2024.

DOI:10.2147/IJN.S467733
PMID:39055376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11269411/
Abstract

BACKGROUND

Prior studies on magnetite (FeO) NPs and carbon nanotubes (CNTs) cytotoxic effects against acute myeloid leukemia (AML) are inconclusive rather than definitive.

PURPOSE

Investigation of the effects of Gum Arabic (GA)-stabilized/destabilized FeO NPs and CNTs, alone or in combination, on AML cell proliferation.

METHODS

Hybrid NPs were synthesized, characterized, and assessed for their cytotoxicity against Kasumi-1, HL-60, and THP-1 in comparison to normal primary bone marrow CD34 cells. The molecular pathways of nanostructures' cytotoxicity were also investigated.

RESULTS

The FeO NPs were effectively synthesized and attached to the surface of the CNTs, resulting in the formation of a novel hybrid through their interaction with the GA colloidal solution in an aqueous media. Although the evaluated nanostructured nanoparticles had significant growth suppression ability against the leukemia cell lines, with IC values ranging from 42.437 to 189.842 μg/mL, they exhibited comparatively modest toxicity towards normal hematopoietic cells (IC: 113.529‒162.656 μg/mL). The incorporation of FeO NPs with CNTs in a hybrid nanocomposite significantly improved their effectiveness against leukemia cells, with the extent of improvement varying depending on the specific cell type. The nanostructured particles were stabilized by GA, which enhances their ability to inhibit cell proliferation in a manner that depends on the specific cell type. Also, nanoparticles exhibit cytotoxicity due to their capacity to stimulate the production of intracellular ROS, halt the cell cycle at the G1 phase, and induce apoptosis. This is supported by the activation of p53, BAX, cytochrome C, and caspase-3, which are triggered by ROS. The nanostructures lead to an increase in the expression of genes encoding proteins related to oxidative stress (SIRT1, FOXO3, NFE2L2, and MAP3K5) and cyclin-dependent kinase inhibitors (CDKN1A and CDKN1B) in response to ROS.

CONCLUSION

We provide an effective FeO NPs/CNTs nano-hybrid composite that induces apoptosis and has strong anti-leukemic capabilities. This hybrid nanocomposite is promising for in vivo testing and validation.

摘要

背景

先前关于磁铁矿(FeO)纳米粒子和碳纳米管(CNT)对急性髓系白血病(AML)的细胞毒性作用的研究结果并不明确。

目的

研究阿拉伯树胶(GA)稳定/不稳定的 FeO 纳米粒子和 CNT 单独或联合使用对 AML 细胞增殖的影响。

方法

合成了杂化纳米粒子,对其进行了表征,并与正常原代骨髓 CD34 细胞进行了比较,评估了它们对 Kasumi-1、HL-60 和 THP-1 的细胞毒性。还研究了纳米结构细胞毒性的分子途径。

结果

成功合成了 FeO 纳米粒子,并将其附着在 CNT 的表面上,通过在水介质中与 GA 胶体溶液相互作用,形成了一种新型的杂化纳米粒子。虽然评估的纳米结构纳米粒子对白血病细胞系具有显著的生长抑制能力,其 IC 值范围为 42.437 至 189.842 μg/mL,但它们对正常造血细胞的毒性相对较小(IC:113.529 至 162.656 μg/mL)。将 FeO 纳米粒子与 CNT 结合在杂化纳米复合材料中,显著提高了它们对白血病细胞的作用,其增强程度取决于特定的细胞类型。GA 稳定了纳米结构颗粒,增强了它们抑制细胞增殖的能力,这种能力取决于特定的细胞类型。此外,纳米颗粒还通过刺激细胞内 ROS 的产生、使细胞周期停滞在 G1 期并诱导细胞凋亡来发挥细胞毒性作用。这得到了 ROS 触发的 p53、BAX、细胞色素 C 和 caspase-3 的激活的支持。纳米结构导致与氧化应激相关的蛋白质(SIRT1、FOXO3、NFE2L2 和 MAP3K5)和细胞周期蛋白依赖性激酶抑制剂(CDKN1A 和 CDKN1B)的编码基因表达增加,以响应 ROS。

结论

我们提供了一种有效的 FeO NPs/CNTs 纳米杂化复合材料,它能诱导细胞凋亡并具有强大的抗白血病能力。这种杂化纳米复合材料有望进行体内测试和验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/790ad3b459a5/IJN-19-7323-g0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/7289042f1f62/IJN-19-7323-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/52e52e74d454/IJN-19-7323-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/ae0d97788bd2/IJN-19-7323-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/db8a9fcee3c8/IJN-19-7323-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/0823b9d10edb/IJN-19-7323-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/aad6b0e5be25/IJN-19-7323-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/57a8ed46c02a/IJN-19-7323-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/511f876df80d/IJN-19-7323-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/909f626a0fdb/IJN-19-7323-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/142e86f23f15/IJN-19-7323-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/3c25ce561bb8/IJN-19-7323-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/4ba9b6454eb9/IJN-19-7323-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/4e2a62373125/IJN-19-7323-g0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/3227f393887b/IJN-19-7323-g0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/790ad3b459a5/IJN-19-7323-g0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/7289042f1f62/IJN-19-7323-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/52e52e74d454/IJN-19-7323-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/ae0d97788bd2/IJN-19-7323-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/db8a9fcee3c8/IJN-19-7323-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/0823b9d10edb/IJN-19-7323-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/aad6b0e5be25/IJN-19-7323-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/57a8ed46c02a/IJN-19-7323-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/511f876df80d/IJN-19-7323-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/909f626a0fdb/IJN-19-7323-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/142e86f23f15/IJN-19-7323-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/3c25ce561bb8/IJN-19-7323-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/4ba9b6454eb9/IJN-19-7323-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/4e2a62373125/IJN-19-7323-g0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/3227f393887b/IJN-19-7323-g0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcc2/11269411/790ad3b459a5/IJN-19-7323-g0015.jpg

相似文献

1
FeO-Coated CNTs-Gum Arabic Nano-Hybrid Composites Exhibit Enhanced Anti-Leukemia Potency Against AML Cells via ROS-Mediated Signaling.FeO 涂层 CNTs-阿拉伯胶纳米杂化复合材料通过 ROS 介导的信号转导增强抗白血病活性,针对 AML 细胞。
Int J Nanomedicine. 2024 Jul 19;19:7323-7352. doi: 10.2147/IJN.S467733. eCollection 2024.
2
ZnO/CNT@FeO induces ROS-mediated apoptosis in chronic myeloid leukemia (CML) cells: an emerging prospective for nanoparticles in leukemia treatment.ZnO/CNT@FeO 诱导慢性髓性白血病 (CML) 细胞产生 ROS 介导的细胞凋亡:纳米颗粒在白血病治疗中的新前景。
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):735-745. doi: 10.1080/21691401.2020.1748885.
3
Azelaic Acid Exerts Antileukemia Effects against Acute Myeloid Leukemia by Regulating the Prdxs/ROS Signaling Pathway.壬二酸通过调节 Prdxs/ROS 信号通路发挥抗急性髓系白血病作用。
Oxid Med Cell Longev. 2020 Dec 23;2020:1295984. doi: 10.1155/2020/1295984. eCollection 2020.
4
Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species.氧化铁纳米颗粒与胞苷阿拉伯糖苷联合通过调节活性氧对急性髓系白血病的白血病干细胞发挥抗作用。
Int J Nanomedicine. 2021 Feb 17;16:1231-1244. doi: 10.2147/IJN.S278885. eCollection 2021.
5
OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis.OSU-A9,一种吲哚-3-甲醇衍生物,通过活性氧介导的细胞凋亡诱导急性髓细胞白血病细胞毒性。
Biochem Pharmacol. 2013 Nov 15;86(10):1430-40. doi: 10.1016/j.bcp.2013.09.002. Epub 2013 Sep 13.
6
Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors.瑞戈非尼通过诱导线粒体依赖性凋亡和细胞周期蛋白依赖性激酶(CDK)抑制剂来抑制急性髓性白血病细胞的增殖。
Eur J Pharmacol. 2016 Oct 15;789:280-290. doi: 10.1016/j.ejphar.2016.07.049. Epub 2016 Jul 28.
7
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.罗地替尼增强阿糖胞苷(Ara-C)诱导的急性髓系白血病细胞死亡。
BMC Cancer. 2020 Dec 4;20(1):1193. doi: 10.1186/s12885-020-07701-8.
8
Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.姜黄素降低了耐柔红霉素 CD34+ 急性髓系白血病细胞系和分选的 CD34+ 急性髓系白血病细胞中 Bcl-2 的表达,导致细胞凋亡。
J Transl Med. 2011 May 19;9:71. doi: 10.1186/1479-5876-9-71.
9
Ethyl acetate extract of Caesalpinia sappan L. inhibited acute myeloid leukemia via ROS-mediated apoptosis and differentiation.苏木乙酸乙酯提取物通过 ROS 介导的细胞凋亡和分化抑制急性髓系白血病。
Phytomedicine. 2020 Mar;68:153142. doi: 10.1016/j.phymed.2019.153142. Epub 2019 Dec 4.
10
Anisotropic Platinum Nanoparticle-Induced Cytotoxicity, Apoptosis, Inflammatory Response, and Transcriptomic and Molecular Pathways in Human Acute Monocytic Leukemia Cells.各向异性铂纳米颗粒诱导的人急性单核细胞白血病细胞的细胞毒性、细胞凋亡、炎症反应及转录组学和分子途径。
Int J Mol Sci. 2020 Jan 9;21(2):440. doi: 10.3390/ijms21020440.

引用本文的文献

1
Critical Evaluation of Combined Cu and FeO Nanodots with Gum Arabic Nano-Hybrids Using in-vitro Model: Flow Cytometry and Cell Viability Studies.使用体外模型对结合铜和氧化亚铁纳米点与阿拉伯树胶纳米杂化物的批判性评估:流式细胞术和细胞活力研究。
Int J Nanomedicine. 2025 Mar 3;20:2593-2607. doi: 10.2147/IJN.S498894. eCollection 2025.
2
A reactive oxygen species-related signature predicts the prognosis and immunosuppressive microenvironment in gliomas.一种与活性氧物种相关的特征可预测脑肿瘤的预后和免疫抑制微环境。
Redox Rep. 2024 Dec;29(1):2433396. doi: 10.1080/13510002.2024.2433396. Epub 2024 Nov 28.

本文引用的文献

1
Nanotechnological advances in cancer: therapy a comprehensive review of carbon nanotube applications.癌症治疗中的纳米技术进展:碳纳米管应用的全面综述
Front Bioeng Biotechnol. 2024 Mar 6;12:1351787. doi: 10.3389/fbioe.2024.1351787. eCollection 2024.
2
Application of carbon nanostructures in biomedicine: realities, difficulties, prospects.碳纳米结构在生物医学中的应用:现状、难点与展望。
Nanotoxicology. 2024 Mar;18(2):181-213. doi: 10.1080/17435390.2024.2327053. Epub 2024 Mar 15.
3
Therapeutic and diagnostic applications of carbon nanotubes in cancer: recent advances and challenges.
碳纳米管在癌症治疗和诊断中的应用:最新进展与挑战。
J Drug Target. 2024 Dec;32(3):287-299. doi: 10.1080/1061186X.2024.2309575. Epub 2024 Feb 1.
4
Recent trends in preparation and biomedical applications of iron oxide nanoparticles.近期氧化铁纳米粒子的制备及生物医学应用的发展趋势。
J Nanobiotechnology. 2024 Jan 8;22(1):24. doi: 10.1186/s12951-023-02235-0.
5
Acute myeloid leukaemia.急性髓细胞白血病。
Lancet. 2023 Jun 17;401(10393):2073-2086. doi: 10.1016/S0140-6736(23)00108-3. Epub 2023 Apr 15.
6
Application of iron oxide nanoparticles in the diagnosis and treatment of leukemia.氧化铁纳米颗粒在白血病诊断与治疗中的应用。
Front Pharmacol. 2023 Mar 30;14:1177068. doi: 10.3389/fphar.2023.1177068. eCollection 2023.
7
Inorganic Nanomaterials Used in Anti-Cancer Therapies:Further Developments.用于抗癌治疗的无机纳米材料:进一步发展
Nanomaterials (Basel). 2023 Mar 22;13(6):1130. doi: 10.3390/nano13061130.
8
Cancer nanomedicine: a review of nano-therapeutics and challenges ahead.癌症纳米医学:纳米治疗方法及未来挑战综述
RSC Adv. 2023 Mar 14;13(13):8606-8629. doi: 10.1039/d2ra07863e.
9
Iron Oxide Nanoparticles: A Review on the Province of Its Compounds, Properties and Biological Applications.氧化铁纳米颗粒:关于其化合物、性质及生物学应用领域的综述
Materials (Basel). 2022 Dec 21;16(1):59. doi: 10.3390/ma16010059.
10
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management.急性髓细胞白血病:2023 年诊断、风险分层和治疗更新。
Am J Hematol. 2023 Mar;98(3):502-526. doi: 10.1002/ajh.26822. Epub 2023 Jan 13.